TickerStat.com

Advanced Biomed Inc. (ADVB)

Price—Loading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

2 annual periodsNewest to oldest
20252024
Research & development$909,771$880,193
Operating expenses$3.0M$2.5M
Net income−$3.3M−$2.8M
Basic EPSper diluted share-$0.16-$0.14
Diluted EPSper diluted share-$0.16-$0.14
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗